BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 22112286)

  • 21. Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Breyer BN; Huang WY; Rabkin CS; Alderete JF; Pakpahan R; Beason TS; Kenfield SA; Mabie J; Ragard L; Wolin KY; Grubb RL; Andriole GL; Sutcliffe S
    BJU Int; 2016 Jan; 117(1):145-54. PubMed ID: 25601300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of inflammation and benign prostatic hyperplasia on autopsy in Asian and Caucasian men.
    Zlotta AR; Egawa S; Pushkar D; Govorov A; Kimura T; Kido M; Takahashi H; Kuk C; Kovylina M; Aldaoud N; Fleshner N; Finelli A; Klotz L; Lockwood G; Sykes J; Kwast Tv
    Eur Urol; 2014 Oct; 66(4):619-22. PubMed ID: 25012523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower urinary tract symptoms have negative associations with glomerular filtration rate irrespective of prostate volume in Korean men.
    Kwon YM; Cho B; Son KY; Choi HC; Park SG; Park JH
    Urology; 2012 Jan; 79(1):182-7. PubMed ID: 21962878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ultrasound indicators of the prostate, urinary bladder and uroflowmetry parameters in the diagnosis of infravesical obstruction in men with benign prostatic hyperplasia].
    Krivoborodov GG; Efremov NS; Bolotov AD
    Urologiia; 2017 Oct; (5):9-14. PubMed ID: 29135135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years or older.
    Berges R; Oelke M
    World J Urol; 2011 Apr; 29(2):171-8. PubMed ID: 21221974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between LUTS (AUA-SS) and erectile dysfunction (SHIM) in an age-matched racially diverse male population: data from the Prostate Cancer Awareness Week (PCAW).
    Barqawi A; O'Donnell C; Kumar R; Koul H; Crawford ED
    Int J Impot Res; 2005; 17(4):370-4. PubMed ID: 15889121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progression and treatment of incident lower urinary tract symptoms (LUTS) among men in the California Men's Health Study.
    Wallner LP; Slezak JM; Loo RK; Quinn VP; Van Den Eeden SK; Jacobsen SJ
    BJU Int; 2015 Jan; 115(1):127-33. PubMed ID: 24840926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benign prostate specific antigen distribution and associations with urological outcomes in community dwelling black and white men.
    Rhodes T; Jacobson DJ; McGree ME; St Sauver JL; Sarma AV; Girman CJ; Lieber MM; Klee GG; Demissie K; Jacobsen SJ
    J Urol; 2012 Jan; 187(1):87-91. PubMed ID: 22093190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.
    Antunes AA; Srougi M; Dall'oglio MF; Vicentini F; Paranhos M; Freire GC
    J Sex Med; 2008 Jul; 5(7):1702-7. PubMed ID: 18194186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limitations of using outcomes in the placebo arm of a clinical trial of benign prostatic hyperplasia to quantify those in the community.
    Roberts RO; Lieber MM; Jacobson DJ; Girman CJ; Jacobsen SJ
    Mayo Clin Proc; 2005 Jun; 80(6):759-64. PubMed ID: 15948299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for lower urinary tract symptoms in a population-based sample of African-American men.
    Joseph MA; Harlow SD; Wei JT; Sarma AV; Dunn RL; Taylor JM; James SA; Cooney KA; Doerr KM; Montie JE; Schottenfeld D
    Am J Epidemiol; 2003 May; 157(10):906-14. PubMed ID: 12746243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The natural history of benign prostatic hyperplasia.
    Fitzpatrick JM
    BJU Int; 2006 Apr; 97 Suppl 2():3-6; discussion 21-2. PubMed ID: 16507045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between Metabolic Syndrome and Predictors for Clinical Benign Prostatic Hyperplasia Progression and International Prostate Symptom Score in Patients with Moderate to Severe Lower Urinary Tract Symptoms.
    Zhao S; Chen C; Chen Z; Xia M; Tang J; Shao S; Yan Y
    Urol J; 2016 Jun; 13(3):2717-26. PubMed ID: 27351328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
    Nickel JC; Elhilali M; Vallancien G;
    BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Sutcliffe S; Grubb Iii RL; Platz EA; Ragard LR; Riley TL; Kazin SS; Hayes RB; Hsing AW; Andriole GL;
    BJU Int; 2012 Oct; 110(7):1050-9. PubMed ID: 22429766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes and benign prostatic hyperplasia progression in Olmsted County, Minnesota.
    Burke JP; Jacobson DJ; McGree ME; Roberts RO; Girman CJ; Lieber MM; Jacobsen SJ
    Urology; 2006 Jan; 67(1):22-5. PubMed ID: 16413325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes and prostate cancer screening in black and white men.
    Sanderson M; Fowke JH; Lipworth L; Han X; Ukoli F; Coker AL; Blot WJ; Hargreaves MK
    Cancer Causes Control; 2013 Oct; 24(10):1893-9. PubMed ID: 23860952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive patient evaluation for benign prostatic hyperplasia.
    Jepsen JV; Bruskewitz RC
    Urology; 1998 Apr; 51(4A Suppl):13-8. PubMed ID: 9586591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.